AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-160184767/optimer-buys-back-rights.html" title="Facts and information about Optimer buys back rights to difimicin.(Optimer Pharmaceuticals )(Brief article)">Optimer buys back rights to difimicin.(Optimer Pharmaceuticals )(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.
Frequently asked questions about RSS feeds
Optimer buys back rights to difimicin.(Optimer Pharmaceuticals )(Brief article)
USA-based biopharmaceutical firm Optimer Pharmaceuticals says that it has regained North American rights to its antibiotic difimicin (PAR-101/OPT-80) from Par Pharmaceuticals, with which it had been collaborating on the product's development. The transaction brings to a close the partnership that was first established in 2005 (Marketletters passim).
Under the terms of the buy-back deal, ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile.
- Press release article from: M2 Presswire September 1, 2008 700+ words
...Available Now - Optimer Pharmaceuticals Inc: Premium...addition of the "Optimer Pharmaceuticals Inc: Premium...Difimicin from Par Pharmaceuticals and Prulifloxacin...Figure 1: Optimer Pharmaceuticals- Operating Revenue...
- Research and Markets: Available Now - Optimer Pharmaceuticals Inc: Premium...
- Press release article from: Business Wire September 1, 2008 700+ words
...addition of the "Optimer Pharmaceuticals Inc: Premium...Difimicin from Par Pharmaceuticals and Prulifloxacin...Figure 1: Optimer Pharmaceuticals- Operating...Figure 2: Optimer Pharmaceuticals- Key Strategic...
- Optimer Pharmaceuticals Reports First Quarter 2007 Financial Results Including...
- Press release article from: Business Wire May 10, 2007 700+ words
SAN DIEGO -- Optimer Pharmaceuticals, Inc. (Nasdaq...million payment to Par Pharmaceuticals to regain the North...North America About Optimer Pharmaceuticals Optimer Pharmaceuticals is a biopharmaceutical...
- Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate...
- Press release article from: PR Newswire April 13, 2009 700+ words
...13 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. announced today that the United...probability of CDI recurrence. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company...
- Optimer Pharmaceuticals to Present at September 2009 Investor Conferences.
- Press release article from: PR Newswire September 3, 2009 700+ words
...3 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced that the Company...days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company...
- Optimer Pharmaceuticals Announces Presentations of Additional Phase 3...
- Press release article from: PR Newswire September 2, 2009 700+ words
...Results from studies related to Optimer Pharmaceuticals, Inc.'s lead developmental product...number: D-1433 in Hall B About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company...
- Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global...
- Press release article from: PR Newswire August 4, 2009 700+ words
...4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. is scheduled to present at...days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company...
- Optimer Pharmaceuticals Announces Publication in Peer-Reviewed Journal about...
- Magazine article from: Women's Health Weekly March 12, 2009 700+ words
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR...causing pathogens (see also Optimer Pharmaceuticals, Inc.). Infectious diarrhea...announced in July 2008. About Optimer Pharmaceuticals Optimer Pharmaceuticals...
